Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

This summer, two of the leading contenders in the great AI race have suddenly, alarmingly, declared that the endgame is in sight and that they’re now spending vast amounts of time and money to try ...